Changning Wang, PhD, is an assistant professor of radiology at Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, Harvard Medical School, where he leads a growing lab. Dr. Wang specializes in developing and applying novel imaging agents for preclinical and clinical research into human disease mechanisms. He developed the novel PET radiotracer [11C]Martinostat to detect epigenetic processes, which was approved by FDA for first-in-human trials. Currently, Dr. Wang is leading pre-clinical and clinical research projects on PET/MR imaging of epigenetic processes in Parkinson's, Huntington’s, and substance use disorders. He is also pursuing the development of other new brain imaging agents.
Dr. Wang earned a doctorate in molecular imaging at Case Western Reserve University and has training and a broad background in molecular imaging, chemistry, pharmaceutical sciences, and neuroscience.